Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 7337 | 18.105 |
09:34 ET | 3667 | 18 |
09:36 ET | 2203 | 18 |
09:38 ET | 8203 | 18 |
09:39 ET | 300 | 18.06 |
09:45 ET | 100 | 18.16 |
09:52 ET | 300 | 18.15 |
09:54 ET | 403 | 18.15 |
09:57 ET | 604 | 18.15 |
09:59 ET | 3800 | 18.15 |
10:01 ET | 574 | 18.14 |
10:03 ET | 4462 | 18.1 |
10:06 ET | 1679 | 18.07 |
10:08 ET | 9700 | 18.03 |
10:10 ET | 845 | 17.935 |
10:12 ET | 300 | 18.01 |
10:14 ET | 300 | 17.905 |
10:15 ET | 1891 | 17.875 |
10:17 ET | 3512 | 17.76 |
10:19 ET | 16305 | 17.7793 |
10:21 ET | 100 | 17.84 |
10:24 ET | 2316 | 17.99 |
10:26 ET | 1330 | 17.94 |
10:28 ET | 11867 | 18.17 |
10:30 ET | 2780 | 18.15 |
10:32 ET | 300 | 18.195 |
10:33 ET | 392 | 18.25 |
10:35 ET | 1100 | 18.27 |
10:37 ET | 656 | 18.155 |
10:39 ET | 3090 | 18.09 |
10:42 ET | 400 | 18.17 |
10:44 ET | 12018 | 17.96 |
10:46 ET | 10975 | 17.955 |
10:48 ET | 910 | 17.99 |
10:50 ET | 200 | 17.985 |
10:51 ET | 100 | 17.94 |
10:53 ET | 1800 | 17.94 |
10:57 ET | 100 | 17.96 |
11:00 ET | 1900 | 17.94 |
11:02 ET | 200 | 17.95 |
11:06 ET | 5737 | 17.93 |
11:09 ET | 200 | 17.96 |
11:11 ET | 200 | 18.03 |
11:15 ET | 1220 | 18.02 |
11:18 ET | 1647 | 18.035 |
11:20 ET | 200 | 18.02 |
11:22 ET | 1813 | 18.01 |
11:24 ET | 200 | 18 |
11:26 ET | 2930 | 18.03 |
11:27 ET | 1896 | 18.03 |
11:29 ET | 381 | 18.065 |
11:31 ET | 1300 | 18.05 |
11:33 ET | 400 | 18.065 |
11:36 ET | 200 | 18.04 |
11:38 ET | 200 | 18.06 |
11:40 ET | 200 | 18.06 |
11:42 ET | 400 | 18.04 |
11:44 ET | 3763 | 18.03 |
11:45 ET | 200 | 18.035 |
11:47 ET | 100 | 18 |
11:49 ET | 100 | 18.02 |
11:54 ET | 1215 | 18 |
11:56 ET | 159 | 18.0251 |
12:00 ET | 200 | 17.99 |
12:03 ET | 1503 | 18.07 |
12:05 ET | 195 | 18.07 |
12:12 ET | 1911 | 18.04 |
12:14 ET | 800 | 18.015 |
12:16 ET | 600 | 18.02 |
12:18 ET | 100 | 18.03 |
12:20 ET | 450 | 18.03 |
12:21 ET | 100 | 18.03 |
12:23 ET | 200 | 18.03 |
12:25 ET | 600 | 18.08 |
12:27 ET | 100 | 18.085 |
12:30 ET | 507 | 18.12 |
12:32 ET | 6600 | 18.22 |
12:34 ET | 100 | 18.205 |
12:36 ET | 2367 | 18.295 |
12:38 ET | 300 | 18.29 |
12:39 ET | 1980 | 18.3 |
12:41 ET | 510 | 18.25 |
12:43 ET | 4430 | 18.27 |
12:45 ET | 2516 | 18.42 |
12:48 ET | 6890 | 18.38 |
12:50 ET | 2544 | 18.3439 |
12:52 ET | 300 | 18.39 |
12:54 ET | 1037 | 18.39 |
12:56 ET | 1200 | 18.37 |
12:57 ET | 700 | 18.46 |
12:59 ET | 6382 | 18.32 |
01:01 ET | 4116 | 18.21 |
01:03 ET | 717 | 18.1601 |
01:06 ET | 100 | 18.17 |
01:08 ET | 13761 | 18.25 |
01:10 ET | 600 | 18.25 |
01:12 ET | 2765 | 18.225 |
01:14 ET | 300 | 18.2 |
01:15 ET | 2090 | 18.19 |
01:17 ET | 2233 | 18.1 |
01:19 ET | 1104 | 18.1011 |
01:21 ET | 1105 | 18.15 |
01:24 ET | 100 | 18.15 |
01:26 ET | 100 | 18.14 |
01:28 ET | 100 | 18.13 |
01:30 ET | 200 | 18.14 |
01:32 ET | 527 | 18.17 |
01:33 ET | 800 | 18.205 |
01:35 ET | 100 | 18.215 |
01:37 ET | 500 | 18.18 |
01:39 ET | 6323 | 18.08 |
01:42 ET | 1326 | 18.07 |
01:44 ET | 200 | 18.05 |
01:46 ET | 600 | 18.04 |
01:48 ET | 192 | 18.065 |
01:50 ET | 907 | 17.98 |
01:51 ET | 512 | 18 |
01:53 ET | 300 | 17.97 |
01:57 ET | 200 | 17.99 |
02:00 ET | 514 | 18.01 |
02:02 ET | 600 | 18.03 |
02:04 ET | 300 | 18.03 |
02:06 ET | 2758 | 18.01 |
02:08 ET | 1790 | 18.05 |
02:09 ET | 696 | 18.07 |
02:11 ET | 7057 | 18.07 |
02:13 ET | 8861 | 18.04 |
02:15 ET | 19105 | 18.03 |
02:18 ET | 320 | 18.02 |
02:20 ET | 100 | 18.01 |
02:22 ET | 2553 | 18 |
02:24 ET | 523 | 17.95 |
02:26 ET | 1998 | 17.92 |
02:27 ET | 360 | 17.9 |
02:29 ET | 200 | 17.89 |
02:31 ET | 1400 | 17.91 |
02:33 ET | 300 | 17.96 |
02:36 ET | 660 | 17.94 |
02:38 ET | 200 | 17.91 |
02:40 ET | 200 | 17.94 |
02:42 ET | 400 | 17.96 |
02:44 ET | 200 | 17.97 |
02:45 ET | 1522 | 17.93 |
02:47 ET | 400 | 17.94 |
02:49 ET | 919 | 18.01 |
02:51 ET | 200 | 18.01 |
02:56 ET | 9700 | 18.06 |
02:58 ET | 2405 | 18.15 |
03:00 ET | 37725 | 18.11 |
03:02 ET | 6224 | 18.02 |
03:03 ET | 2303 | 18.07 |
03:05 ET | 1221 | 18.09 |
03:07 ET | 1300 | 18.07 |
03:12 ET | 7434 | 18.03 |
03:14 ET | 2641 | 18.06 |
03:16 ET | 2812 | 18.03 |
03:18 ET | 1999 | 18.02 |
03:20 ET | 7328 | 18.1 |
03:21 ET | 15829 | 18.07 |
03:23 ET | 5595 | 18.065 |
03:25 ET | 4439 | 18.11 |
03:27 ET | 200 | 18.1 |
03:30 ET | 4545 | 18.17 |
03:32 ET | 1522 | 18.1 |
03:34 ET | 572 | 18.13 |
03:36 ET | 8097 | 18.18 |
03:38 ET | 14100 | 18.08 |
03:39 ET | 13375 | 18.05 |
03:41 ET | 804 | 18.04 |
03:43 ET | 2436 | 18.05 |
03:45 ET | 2939 | 18.11 |
03:48 ET | 2608 | 18.09 |
03:50 ET | 2667 | 18.07 |
03:52 ET | 19501 | 18.1 |
03:54 ET | 41270 | 18.055 |
03:56 ET | 13353 | 18.08 |
03:57 ET | 39885 | 18.27 |
03:59 ET | 198520 | 18.24 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.6B | -5.9x | --- |
Ardelyx Inc | 1.4B | -20.9x | --- |
Gyre Therapeutics Inc | 1.3B | -16.2x | --- |
Travere Therapeutics Inc | 1.4B | -3.7x | --- |
Nurix Therapeutics Inc | 1.8B | -8.5x | --- |
Xencor Inc | 1.5B | -7.4x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
---|---|
Revenue (TTM) | $247.0M |
Shares Outstanding | 91.4M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.89 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -5.9x |
Price/Sales (TTM) | 6.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -118.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.